Boehringer Ingelheim Investigational Site
Auckland
0 studies enrolling now · 4 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Hypertension, Pulmonary Disease, Chronic Obstructive
Studies at this site
- A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) — Completed
- Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC — Completed
- Tiotropium / Respimat One-Year Study — Completed
- SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed